Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

In this issue

Research

Close-up view of female doctor hand holding pills pack and writing prescription

Impact of including clinical indications on inpatient prescriptionsSubscription

By , , , ,

The appropriate use of medicines is dependant on the accurate use of clinical indications on inpatient paper and electronic prescriptions. This mixed-methods study involving semi-structured interviews with 64 chief pharmacists, 11 focus groups from three NHS trusts and a medical documentation review of 89 patients determined both positive and negative implications of including clinical indications on healthcare professionals’ clinical workflow.

Insight

A flowchart illustrating how treatment for T2DM can be personalised

Personalising treatment for type 2 diabetes: why is NICE so behind?Subscription

By ,

The National Institute for Health and Care Excellence’s rudimentary approach to managing diabetes needs to catch up with the available evidence and put patients centre stage.

CPD article

Illustration of cytochrome P450. Enzymes within the cytochrome P450 superfamily are essential for the metabolism of many medicines

Tobacco smoking and its potential drug interactionsSubscription

By , , ,

Smoking and smoking cessation treatments have a pharmacological impact on some commonly used drugs and should be taken into account during the selection, introduction and cessation of medicines.

Short communications

Recruiting community pharmacies to a smoking support service trial using the 'Russian doll' approachSubscription

‘Smoking Treatment Optimisation in Pharmacies’ (STOP) is a six-year programme funded by the National Institute for Health Research. STOP is a complex intervention based on behavioural theory, and involves training for pharmacy staff and associated study materials, such as badges and posters. The STOP trial is assessing the effectiveness and cost-effectiveness of the STOP intervention on smoker recruitment, retention and quit rates in the NHS stop smoking service based in community pharmacy. ...

Managing interstitial lung disease: impact of involving a specialist respiratory pharmacistSubscription

Interstitial lung disease (ILD) is an umbrella term describing a diverse group of lung diseases that result in impairment or fibrosis of the alveolar interstitium. Idiopathic interstitial pneumonias are the most common ILDs; and idiopathic pulmonary fibrosis (IPF) is most common among this cohort of patients. Symptoms of ILD include breathlessness and a persistent, dry and irritating cough. Patients with ILD may experience acute exacerbations, which can increase the burden of disease, ...

Clinical Pharmacist

cover cp 11 01 19

CP January 2019, Vol 11, No 1

Cover Story:

Tobacco smoking and its potential drug interactions

Read more…

Clinical Pharmacist

View previous issue

Clinical Pharmacist is a monthly, peer-reviewed journal that provides authoritative resources on the clinical management of disease in relation to medicines and up-to-date information about advances in pharmacy and drug development. Clinical Pharmacist publishes Review articles, Perspectives, evidence-based CPD articles and Research articles on topics from drug discovery to clinical pharmacology and pharmacy.

The international audience of Pharmaceutical Journal Publications consists of pharmacists, pharmaceutical scientists and healthcare professionals. The journal is available to 44,000 members of the Royal Pharmaceutical Society, as well as non-member individual subscribers and subscribing institutions.